13F Data
13F filer · CIK 1643354

Lion Point Capital, LP

NEW YORK, NY · filing since Q4 2015 · last filing Aug 14, 2026
Reported value
$20.9M
+$4.2M vs prior
Positions
35
New / sold out
1 / 1
Added / reduced
0 / 0
Turnover
2.7%
buys $1.7M · sells $506.4K
Top-10 weight
55.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewCUE BIOPHARMA INC+52,928–+$1.7M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outCUE BIOPHARMA INC-2,202,854-100.0%$-506.4K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2015: $328.5MQ1 2016: $346.3MQ2 2016: $376.5MQ3 2016: $761.0MQ4 2016: $411.5MQ1 2017: $684.1MQ2 2017: $720.5MQ3 2017: $1.2BQ4 2017: $1.3BQ1 2018: $1.1BQ2 2018: $1.1BQ3 2018: $1.1BQ4 2018: $463.9MQ1 2019: $1.1BQ2 2019: $1.0BQ3 2019: $896.7MQ4 2019: $1.1BQ1 2020: $378.9MQ2 2020: $412.3MQ3 2020: $455.9MQ4 2020: $519.2MQ1 2021: $549.6MQ2 2021: $578.6MQ3 2021: $533.4MQ4 2021: $373.0MQ1 2022: $430.9MQ2 2022: $878.5MQ3 2022: $453.9MQ4 2022: $699.4MQ1 2023: $242.9MQ2 2023: $221.3MQ3 2023: $224.4MQ4 2023: $199.9MQ1 2024: $179.0MQ2 2024: $54.9MQ3 2024: $44.9MQ4 2024: $19.1MQ1 2025: $15.7MQ2 2025: $14.7MQ3 2025: $17.6MQ4 2025: $19.3MQ1 2026: $16.7MQ2 2026: $20.9M
Q4 2015Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1CUE BIOPHARMA INCCOM52,928$1.7M7.99%
2PRAXIS PRECISION MEDICINES ICOM NEW4,450$1.5M7.13%
3MOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD67,500$1.3M6.29%
4FENNEC PHARMACEUTICALS INCCOM112,434$1.2M5.78%
5ROYALTY PHARMA PLCSHS CLASS A21,400$1.2M5.74%
6COMPASS PATHWAYS PLCSPONSORED ADS80,000$1.1M5.41%
7MILESTONE PHARMACEUTICALS INCOM820,000$1.1M5.26%
8BENITEC BIOPHARMA INCCOM NEW62,000$829.6K3.97%
9SYNDAX PHARMACEUTICALS INCCOM36,000$787.0K3.76%
10BIOHAVEN LTDCOM51,700$769.3K3.68%
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.